| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
|
273,073 |
218,838 |
$18.10M |
| 99214 |
|
84,559 |
66,963 |
$7.28M |
| T2023 |
Targeted case management; per month |
16,284 |
16,153 |
$6.79M |
| 96361 |
|
42,385 |
29,542 |
$4.93M |
| 99283 |
|
45,827 |
40,620 |
$2.71M |
| 87635 |
|
42,603 |
37,790 |
$2.70M |
| 99284 |
|
46,442 |
41,408 |
$2.65M |
| A0431 |
Ambulance service, conventional air services, transport, one way (rotary wing) |
1,743 |
1,256 |
$2.54M |
| 80053 |
|
79,593 |
63,979 |
$2.48M |
| 96365 |
|
34,233 |
20,996 |
$2.46M |
| 99285 |
|
34,034 |
29,750 |
$1.79M |
| Q3014 |
Telehealth originating site facility fee |
44,704 |
37,014 |
$1.67M |
| 80048 |
|
61,317 |
49,035 |
$1.58M |
| 99215 |
Prolong outpt/office vis |
15,097 |
12,611 |
$1.37M |
| 99203 |
|
19,409 |
18,308 |
$1.29M |
| 87637 |
|
10,860 |
10,207 |
$1.18M |
| 43239 |
|
5,415 |
5,036 |
$1.02M |
| 96360 |
|
11,797 |
10,236 |
$1.01M |
| 70553 |
|
10,477 |
9,391 |
$1.00M |
| 74177 |
|
14,942 |
13,476 |
$986K |
| 97110 |
|
49,094 |
29,908 |
$978K |
| A0436 |
Rotary wing air mileage, per statute mile |
1,733 |
1,250 |
$975K |
| 77386 |
|
7,997 |
764 |
$970K |
| 85025 |
|
121,685 |
96,343 |
$833K |
| 96366 |
|
9,054 |
6,195 |
$811K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
102,383 |
78,916 |
$790K |
| 64643 |
|
5,001 |
3,480 |
$777K |
| 93306 |
|
6,384 |
5,978 |
$739K |
| 82306 |
|
18,656 |
17,118 |
$735K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,113 |
910 |
$718K |
| 70450 |
|
11,692 |
10,318 |
$706K |
| 96413 |
|
10,854 |
5,982 |
$701K |
| 81001 |
|
60,484 |
50,284 |
$699K |
| J0588 |
Injection, incobotulinumtoxin a, 1 unit |
6,223 |
5,940 |
$595K |
| 45380 |
|
3,745 |
3,478 |
$587K |
| 87491 |
|
14,699 |
12,858 |
$578K |
| 97530 |
|
13,661 |
9,265 |
$573K |
| 99281 |
|
8,966 |
8,160 |
$562K |
| 99204 |
|
6,803 |
6,252 |
$547K |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
1,349 |
839 |
$540K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
43,003 |
38,573 |
$536K |
| 80307 |
|
12,298 |
10,042 |
$496K |
| 99282 |
|
9,187 |
8,286 |
$486K |
| 76770 |
|
5,385 |
5,116 |
$472K |
| 94640 |
|
18,836 |
7,502 |
$463K |
| 87631 |
|
4,906 |
4,399 |
$444K |
| 42820 |
|
925 |
877 |
$429K |
| 64642 |
|
3,345 |
3,185 |
$427K |
| 93303 |
|
2,213 |
2,073 |
$410K |
| 80061 |
|
16,422 |
15,090 |
$397K |
| 87591 |
|
15,097 |
12,883 |
$372K |
| 45385 |
|
2,089 |
1,947 |
$372K |
| 80197 |
|
12,506 |
7,965 |
$370K |
| 83036 |
|
22,537 |
20,514 |
$366K |
| 96040 |
|
2,782 |
2,579 |
$348K |
| 70551 |
|
3,424 |
3,100 |
$343K |
| 93321 |
|
3,032 |
2,821 |
$337K |
| 41899 |
|
880 |
816 |
$337K |
| 71275 |
|
4,584 |
4,162 |
$330K |
| 69436 |
|
1,013 |
947 |
$326K |
| 97162 |
|
9,656 |
8,843 |
$321K |
| 92567 |
|
7,467 |
7,020 |
$317K |
| 92507 |
|
8,932 |
5,469 |
$310K |
| 96367 |
|
4,655 |
3,464 |
$310K |
| 96138 |
|
2,256 |
1,900 |
$291K |
| 97112 |
|
11,202 |
7,349 |
$290K |
| 99391 |
|
4,890 |
4,374 |
$281K |
| 84443 |
|
24,441 |
22,050 |
$279K |
| J0475 |
Injection, baclofen, 10 mg |
2,572 |
2,450 |
$277K |
| 76705 |
|
8,128 |
7,412 |
$277K |
| 93320 |
|
2,221 |
2,061 |
$271K |
| G0378 |
Hospital observation service, per hour |
14,491 |
7,336 |
$265K |
| 92523 |
|
2,825 |
2,603 |
$261K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
3,432 |
3,148 |
$258K |
| 93308 |
|
1,708 |
1,602 |
$256K |
| 82728 |
|
15,459 |
14,082 |
$255K |
| 80051 |
|
10,415 |
8,408 |
$249K |
| 96139 |
|
2,244 |
1,848 |
$240K |
| 82565 |
|
24,291 |
19,548 |
$232K |
| 93325 |
|
5,585 |
5,135 |
$230K |
| 87081 |
|
5,550 |
4,848 |
$229K |
| 96415 |
|
2,260 |
1,485 |
$228K |
| 72148 |
|
4,088 |
3,683 |
$228K |
| 99392 |
|
4,264 |
4,084 |
$227K |
| C9257 |
Injection, bevacizumab, 0.25 mg |
1,885 |
1,710 |
$225K |
| 82962 |
|
34,931 |
18,144 |
$223K |
| 87086 |
|
18,976 |
16,305 |
$223K |
| 74183 |
|
2,550 |
2,286 |
$223K |
| 52000 |
|
946 |
902 |
$222K |
| 84484 |
|
34,068 |
23,553 |
$221K |
| 93356 |
|
2,329 |
2,141 |
$220K |
| 77336 |
|
4,010 |
1,865 |
$217K |
| 82247 |
|
14,061 |
11,279 |
$214K |
| 97140 |
|
14,300 |
8,247 |
$212K |
| G0175 |
Scheduled interdisciplinary team conference (minimum of three exclusive of patient care nursing staff) with patient present |
4,590 |
4,310 |
$211K |
| 87077 |
|
14,806 |
10,293 |
$204K |
| 62370 |
|
1,551 |
1,492 |
$202K |
| 76497 |
|
9,611 |
8,654 |
$197K |
| 20553 |
|
2,993 |
2,795 |
$196K |
| 78452 |
|
1,481 |
1,379 |
$195K |
| 87070 |
|
7,270 |
5,342 |
$195K |
| 84702 |
|
11,986 |
10,345 |
$194K |
| 74176 |
|
3,528 |
3,156 |
$193K |
| 74230 |
|
2,127 |
1,973 |
$191K |
| 81025 |
|
18,525 |
16,386 |
$191K |
| 64615 |
|
2,850 |
2,648 |
$191K |
| 20610 |
|
3,587 |
3,088 |
$190K |
| 85027 |
|
34,436 |
26,679 |
$189K |
| 36430 |
|
1,867 |
1,244 |
$189K |
| 87624 |
|
4,555 |
4,094 |
$188K |
| 83880 |
|
8,811 |
7,707 |
$184K |
| 99393 |
|
2,935 |
2,840 |
$182K |
| 86832 |
|
3,569 |
3,124 |
$170K |
| 73721 |
|
2,693 |
2,329 |
$167K |
| 49083 |
|
1,013 |
425 |
$167K |
| 90837 |
|
2,912 |
1,763 |
$165K |
| 95816 |
|
1,411 |
1,336 |
$165K |
| 87389 |
|
8,505 |
7,635 |
$164K |
| 92609 |
|
3,796 |
2,423 |
$162K |
| 83735 |
|
40,382 |
30,661 |
$161K |
| 31575 |
|
2,261 |
2,057 |
$158K |
| 95874 |
|
3,968 |
3,784 |
$158K |
| 45378 |
|
814 |
757 |
$157K |
| 88175 |
|
6,425 |
5,627 |
$153K |
| 72141 |
|
2,435 |
2,216 |
$152K |
| 83970 |
|
7,457 |
5,899 |
$152K |
| 96130 |
|
1,158 |
915 |
$151K |
| 96417 |
|
2,956 |
1,691 |
$148K |
| 72197 |
|
1,507 |
1,317 |
$147K |
| 49452 |
|
730 |
684 |
$146K |
| 71260 |
|
2,604 |
2,317 |
$146K |
| 99394 |
|
2,101 |
2,035 |
$144K |
| 83605 |
|
22,530 |
16,080 |
$143K |
| 86833 |
|
3,598 |
3,148 |
$141K |
| 93304 |
|
702 |
648 |
$140K |
| 84439 |
|
9,466 |
8,499 |
$139K |
| 20611 |
|
1,385 |
1,257 |
$137K |
| 64644 |
|
1,838 |
1,756 |
$136K |
| 86850 |
|
16,195 |
14,072 |
$133K |
| 97166 |
|
3,882 |
3,521 |
$133K |
| 71250 |
|
5,562 |
5,003 |
$130K |
| 87507 |
|
404 |
371 |
$130K |
| 87661 |
|
5,655 |
5,136 |
$129K |
| 70546 |
|
1,377 |
1,294 |
$127K |
| 70496 |
|
1,678 |
1,516 |
$125K |
| 85610 |
|
25,430 |
20,650 |
$125K |
| 97161 |
|
4,556 |
4,058 |
$124K |
| 87536 |
|
2,238 |
1,946 |
$123K |
| J2357 |
Injection, omalizumab, 5 mg |
591 |
453 |
$122K |
| 72125 |
|
4,948 |
4,445 |
$117K |
| 43235 |
|
638 |
606 |
$115K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
1,927 |
1,730 |
$114K |
| 92579 |
|
2,178 |
2,068 |
$112K |
| 52310 |
|
465 |
420 |
$109K |
| 17250 |
|
860 |
762 |
$109K |
| 82784 |
|
10,211 |
5,144 |
$109K |
| 67028 |
|
2,967 |
2,695 |
$108K |
| 82803 |
|
6,672 |
5,079 |
$107K |
| 82040 |
|
6,457 |
5,474 |
$106K |
| 93017 |
|
2,863 |
2,595 |
$106K |
| 86780 |
|
6,272 |
5,632 |
$105K |
| 70498 |
|
1,475 |
1,344 |
$104K |
| 16020 |
|
2,048 |
1,272 |
$104K |
| 70491 |
|
1,653 |
1,492 |
$104K |
| 83690 |
|
25,894 |
21,834 |
$104K |
| 94010 |
|
7,960 |
7,115 |
$102K |
| 72158 |
|
1,168 |
1,056 |
$101K |
| 77412 |
|
888 |
129 |
$101K |
| 99205 |
Prolong outpt/office vis |
1,265 |
1,160 |
$100K |
| 93296 |
|
4,470 |
4,297 |
$98K |
| 92526 |
|
2,374 |
1,800 |
$97K |
| 86803 |
|
7,978 |
7,066 |
$96K |
| 97116 |
|
5,104 |
3,114 |
$96K |
| 86480 |
|
2,046 |
1,807 |
$95K |
| 82805 |
|
4,191 |
3,438 |
$95K |
| 87633 |
|
434 |
355 |
$95K |
| 87653 |
|
1,188 |
1,131 |
$94K |
| 93971 |
|
3,649 |
3,296 |
$92K |
| 76830 |
|
3,395 |
3,112 |
$92K |
| 99211 |
|
1,846 |
1,436 |
$90K |
| 87102 |
|
6,627 |
5,746 |
$88K |
| 92610 |
|
1,642 |
1,522 |
$88K |
| 96372 |
|
23,097 |
14,984 |
$88K |
| 84466 |
|
10,979 |
10,125 |
$88K |
| 95886 |
|
1,807 |
1,671 |
$85K |
| 95700 |
|
685 |
645 |
$84K |
| 95819 |
|
791 |
752 |
$84K |
| 87497 |
|
3,336 |
2,245 |
$83K |
| 87799 |
|
5,408 |
3,436 |
$83K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,034 |
1,748 |
$83K |
| 72156 |
|
917 |
816 |
$81K |
| 90686 |
|
10,055 |
9,402 |
$81K |
| 92611 |
|
1,372 |
1,274 |
$81K |
| 82105 |
|
3,519 |
3,111 |
$81K |
| 90834 |
|
1,179 |
863 |
$80K |
| 62369 |
|
826 |
784 |
$80K |
| 76536 |
|
2,017 |
1,859 |
$80K |
| 87641 |
|
3,706 |
3,128 |
$79K |
| 83655 |
|
2,700 |
2,570 |
$78K |
| 96131 |
|
768 |
595 |
$78K |
| 97165 |
|
2,574 |
2,286 |
$77K |
| 77301 |
|
411 |
364 |
$75K |
| 87640 |
|
2,726 |
2,501 |
$75K |
| 87798 |
|
1,878 |
1,199 |
$73K |
| 82607 |
|
5,911 |
5,363 |
$72K |
| 29405 |
|
754 |
536 |
$71K |
| 88305 |
|
28,766 |
19,133 |
$71K |
| 96156 |
|
1,220 |
1,081 |
$71K |
| 97113 |
|
2,958 |
1,340 |
$70K |
| 29075 |
|
969 |
830 |
$69K |
| 84450 |
|
17,815 |
15,054 |
$69K |
| 80050 |
|
5,704 |
5,222 |
$69K |
| 93975 |
|
1,418 |
1,323 |
$69K |
| 43762 |
|
1,515 |
1,399 |
$68K |
| 12001 |
|
1,063 |
1,001 |
$68K |
| 80069 |
|
2,422 |
2,123 |
$68K |
| 82570 |
|
15,296 |
12,567 |
$68K |
| 87522 |
Neg quan hep c or qual rna |
2,232 |
1,956 |
$67K |
| 82077 |
|
7,897 |
6,701 |
$67K |
| 77300 |
|
1,496 |
1,156 |
$67K |
| 84460 |
|
20,647 |
17,374 |
$66K |
| 96136 |
|
854 |
678 |
$66K |
| 91322 |
|
1,031 |
977 |
$66K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
1,204 |
1,067 |
$64K |
| 96137 |
|
811 |
634 |
$64K |
| 94060 |
|
2,375 |
2,205 |
$63K |
| 87880 |
|
4,790 |
4,452 |
$63K |
| 86003 |
|
8,868 |
1,104 |
$61K |
| 97163 |
|
2,286 |
2,109 |
$61K |
| 76857 |
|
3,535 |
3,242 |
$60K |
| 93798 |
|
983 |
657 |
$60K |
| 93005 |
|
58,662 |
47,329 |
$60K |
| 92524 |
|
1,508 |
1,391 |
$59K |
| 70486 |
|
1,623 |
1,462 |
$59K |
| 95716 |
|
420 |
333 |
$58K |
| 84145 |
|
4,211 |
3,775 |
$58K |
| 96101 |
|
317 |
187 |
$57K |
| 92557 |
|
1,899 |
1,772 |
$57K |
| 94660 |
|
1,678 |
941 |
$57K |
| 80164 |
|
1,231 |
1,075 |
$56K |
| 81003 |
|
3,061 |
2,575 |
$56K |
| 70544 |
|
859 |
781 |
$56K |
| 86359 |
|
2,172 |
1,863 |
$55K |
| J0178 |
Injection, aflibercept, 1 mg |
383 |
348 |
$55K |
| 64616 |
|
476 |
447 |
$55K |
| 82310 |
|
4,995 |
4,160 |
$54K |
| 51784 |
|
1,024 |
958 |
$54K |
| 87340 |
|
6,873 |
6,035 |
$54K |
| 64400 |
|
579 |
438 |
$54K |
| 72157 |
|
617 |
542 |
$54K |
| 82043 |
|
4,620 |
4,126 |
$54K |
| 96368 |
|
797 |
623 |
$52K |
| 83540 |
|
11,162 |
10,282 |
$52K |
| 80143 |
|
4,399 |
3,768 |
$52K |
| 86140 |
|
16,224 |
13,678 |
$52K |
| 86762 |
|
1,834 |
1,672 |
$52K |
| 92083 |
|
2,517 |
2,355 |
$52K |
| 31622 |
|
213 |
191 |
$52K |
| 92582 |
|
1,622 |
1,548 |
$52K |
| 71046 |
|
22,416 |
19,713 |
$51K |
| 76499 |
|
1,340 |
1,246 |
$51K |
| 86704 |
|
4,404 |
3,821 |
$51K |
| 90670 |
|
2,674 |
2,563 |
$51K |
| 76882 |
|
1,577 |
1,383 |
$51K |
| 97535 |
|
3,596 |
2,435 |
$51K |
| 76642 |
|
1,880 |
1,694 |
$51K |
| 77002 |
|
2,224 |
1,868 |
$51K |
| 77334 |
|
1,272 |
922 |
$50K |
| 72146 |
|
854 |
788 |
$49K |
| 87186 |
|
10,252 |
7,708 |
$49K |
| 86360 |
|
1,614 |
1,403 |
$48K |
| 86900 |
|
15,522 |
13,152 |
$48K |
| 73221 |
|
891 |
782 |
$48K |
| 82947 |
|
12,121 |
9,692 |
$48K |
| 77067 |
|
2,075 |
1,951 |
$47K |
| 74018 |
|
4,552 |
3,794 |
$47K |
| 95117 |
|
1,683 |
925 |
$47K |
| 77080 |
|
830 |
781 |
$47K |
| 84100 |
|
16,481 |
12,117 |
$46K |
| 81220 |
|
180 |
174 |
$46K |
| 87015 |
|
2,572 |
1,463 |
$46K |
| 86706 |
|
5,241 |
4,569 |
$46K |
| 82977 |
|
9,212 |
7,531 |
$46K |
| 72082 |
|
2,636 |
2,508 |
$45K |
| 92552 |
|
1,055 |
978 |
$44K |
| 96119 |
|
255 |
203 |
$44K |
| 92607 |
|
769 |
727 |
$43K |
| 64450 |
|
785 |
662 |
$43K |
| 95885 |
|
950 |
789 |
$43K |
| 11102 |
|
522 |
484 |
$42K |
| 87506 |
|
318 |
288 |
$42K |
| 92555 |
|
1,147 |
1,098 |
$41K |
| 96110 |
|
177 |
170 |
$41K |
| 72128 |
|
1,732 |
1,545 |
$41K |
| 96111 |
|
179 |
138 |
$41K |
| 86923 |
|
3,482 |
1,901 |
$41K |
| 87205 |
|
13,619 |
10,787 |
$41K |
| 50200 |
|
390 |
357 |
$40K |
| 90651 |
|
1,394 |
1,342 |
$40K |
| 96152 |
|
1,185 |
825 |
$40K |
| 92504 |
|
2,498 |
2,291 |
$40K |
| 87040 |
|
5,645 |
2,966 |
$40K |
| 85379 |
|
6,513 |
5,887 |
$39K |
| 80179 |
|
4,251 |
3,662 |
$39K |
| 94618 |
|
2,362 |
2,060 |
$38K |
| 12011 |
|
628 |
587 |
$38K |
| 96150 |
|
567 |
478 |
$38K |
| 82550 |
|
5,603 |
4,635 |
$38K |
| 64405 |
|
461 |
417 |
$37K |
| 29581 |
|
353 |
78 |
$37K |
| 99395 |
|
680 |
645 |
$37K |
| 96374 |
|
36,310 |
30,282 |
$36K |
| 85652 |
|
13,978 |
11,850 |
$36K |
| 93976 |
|
1,260 |
1,133 |
$35K |
| J9271 |
Injection, pembrolizumab, 1 mg |
31 |
26 |
$35K |
| 93797 |
|
824 |
205 |
$35K |
| 96116 |
|
259 |
194 |
$34K |
| 82950 |
|
839 |
793 |
$34K |
| 87493 |
|
1,125 |
893 |
$34K |
| 82533 |
|
2,367 |
1,893 |
$34K |
| 82670 |
|
902 |
805 |
$33K |
| 84075 |
|
11,393 |
9,408 |
$33K |
| 84403 |
|
1,683 |
1,494 |
$33K |
| 92134 |
|
7,581 |
6,909 |
$32K |
| 93225 |
|
2,136 |
2,019 |
$31K |
| 82140 |
|
2,170 |
1,846 |
$31K |
| 85730 |
|
8,434 |
7,379 |
$31K |
| 64447 |
|
296 |
263 |
$31K |
| 84156 |
|
11,087 |
9,104 |
$30K |
| J9299 |
Injection, nivolumab, 1 mg |
33 |
26 |
$30K |
| 82746 |
|
3,536 |
3,200 |
$29K |
| 76870 |
|
1,010 |
919 |
$29K |
| 86901 |
|
15,523 |
13,153 |
$29K |
| 84132 |
|
6,595 |
4,888 |
$28K |
| 90677 |
|
1,541 |
1,427 |
$28K |
| 90680 |
|
1,965 |
1,910 |
$28K |
| 81229 |
|
60 |
55 |
$28K |
| 51705 |
|
922 |
794 |
$28K |
| 77338 |
|
436 |
384 |
$28K |
| 86038 |
|
3,073 |
2,718 |
$28K |
| 86235 |
|
914 |
606 |
$28K |
| 95951 |
|
170 |
131 |
$28K |
| 86160 |
|
3,055 |
1,475 |
$28K |
| 17110 |
|
583 |
521 |
$27K |
| 90734 |
|
1,526 |
1,452 |
$27K |
| 77063 |
|
1,573 |
1,477 |
$27K |
| 31579 |
|
234 |
208 |
$27K |
| 83615 |
|
7,100 |
5,498 |
$26K |
| 97167 |
|
671 |
623 |
$26K |
| 82150 |
|
3,251 |
2,528 |
$26K |
| 90911 |
|
249 |
152 |
$26K |
| 95004 |
|
1,727 |
1,577 |
$26K |
| 51741 |
|
735 |
675 |
$24K |
| 83520 |
|
1,301 |
1,083 |
$24K |
| 83021 |
|
893 |
766 |
$24K |
| 83516 |
|
1,835 |
1,475 |
$24K |
| 90471 |
|
11,608 |
10,625 |
$24K |
| 82330 |
|
2,488 |
2,048 |
$23K |
| 85048 |
|
3,434 |
2,553 |
$23K |
| G0008 |
Administration of influenza virus vaccine |
5,807 |
5,313 |
$23K |
| 94003 |
|
92 |
57 |
$23K |
| 72131 |
|
849 |
772 |
$22K |
| 71555 |
|
165 |
156 |
$22K |
| 84295 |
|
1,683 |
1,339 |
$21K |
| 52356 |
|
31 |
29 |
$21K |
| 87206 |
|
6,362 |
4,469 |
$20K |
| 97602 |
|
1,454 |
1,226 |
$20K |
| 81000 |
|
1,342 |
1,116 |
$20K |
| 84520 |
|
10,063 |
8,279 |
$20K |
| 84153 |
|
1,560 |
1,361 |
$20K |
| 84481 |
|
1,556 |
1,386 |
$19K |
| 76881 |
|
663 |
551 |
$19K |
| 88307 |
|
3,042 |
2,154 |
$19K |
| 64415 |
|
113 |
96 |
$19K |
| 76942 |
|
5,213 |
4,755 |
$19K |
| 93970 |
|
513 |
478 |
$19K |
| 85018 |
|
7,902 |
6,413 |
$19K |
| 99291 |
|
248 |
226 |
$19K |
| 93226 |
|
2,137 |
2,012 |
$19K |
| 97597 |
|
509 |
357 |
$19K |
| 10060 |
|
352 |
315 |
$19K |
| 87529 |
|
444 |
375 |
$18K |
| 90791 |
|
1,111 |
800 |
$18K |
| 92522 |
|
400 |
375 |
$18K |
| 43760 |
|
263 |
233 |
$18K |
| 82525 |
|
1,078 |
1,008 |
$18K |
| 70543 |
|
147 |
132 |
$18K |
| 85014 |
|
5,960 |
4,732 |
$18K |
| 90716 |
|
605 |
582 |
$18K |
| 88342 |
|
7,039 |
5,539 |
$18K |
| 86708 |
|
2,123 |
1,812 |
$18K |
| 72170 |
|
4,877 |
4,455 |
$17K |
| 86769 |
|
608 |
560 |
$17K |
| 81329 |
|
160 |
155 |
$17K |
| 88341 |
|
3,517 |
2,016 |
$17K |
| 85049 |
|
1,477 |
1,292 |
$17K |
| 90647 |
|
2,276 |
2,205 |
$17K |
| 83993 |
|
523 |
477 |
$16K |
| 84146 |
|
807 |
705 |
$16K |
| 96376 |
|
15,564 |
10,339 |
$16K |
| 73130 |
|
4,340 |
3,448 |
$16K |
| 77066 |
Tomosynthesis, mammo |
886 |
840 |
$16K |
| 82465 |
|
769 |
682 |
$16K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
158 |
65 |
$16K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
41 |
36 |
$15K |
| 84630 |
|
1,539 |
1,462 |
$15K |
| 0001A |
|
1,561 |
1,427 |
$15K |
| 64483 |
|
111 |
105 |
$15K |
| 73630 |
|
5,385 |
4,457 |
$15K |
| J0741 |
Injection, cabotegravir and rilpivirine, 2mg/3mg |
13 |
13 |
$15K |
| 0002A |
|
1,401 |
1,309 |
$15K |
| 84550 |
|
4,200 |
3,529 |
$15K |
| 76937 |
|
1,310 |
1,094 |
$15K |
| 90715 |
|
2,829 |
2,668 |
$15K |
| 31624 |
|
57 |
40 |
$15K |
| 87075 |
|
2,766 |
1,548 |
$14K |
| 86356 |
|
528 |
402 |
$14K |
| 73610 |
|
5,087 |
4,081 |
$14K |
| 94726 |
|
2,272 |
2,066 |
$14K |
| 86364 |
|
1,756 |
1,628 |
$14K |
| 69210 |
|
663 |
627 |
$14K |
| 36415 |
|
118,055 |
80,036 |
$14K |
| 86355 |
|
557 |
477 |
$14K |
| 89051 |
|
2,797 |
1,703 |
$14K |
| 83001 |
|
733 |
670 |
$14K |
| 90480 |
|
1,019 |
987 |
$14K |
| 73502 |
|
3,563 |
3,157 |
$14K |
| 84305 |
|
535 |
505 |
$14K |
| 74174 |
|
198 |
186 |
$14K |
| 86592 |
|
1,523 |
1,298 |
$13K |
| 96450 |
|
104 |
91 |
$13K |
| 20552 |
|
201 |
188 |
$13K |
| 86255 |
|
1,330 |
760 |
$13K |
| 92133 |
|
2,477 |
2,311 |
$13K |
| 95911 |
|
324 |
292 |
$13K |
| 73090 |
|
2,386 |
1,750 |
$13K |
| 71045 |
|
14,731 |
12,701 |
$12K |
| 73030 |
|
4,699 |
3,935 |
$12K |
| 82785 |
|
561 |
508 |
$12K |
| 90633 |
|
1,633 |
1,562 |
$12K |
| 94729 |
|
3,497 |
3,217 |
$12K |
| 80175 |
|
395 |
347 |
$12K |
| 96375 |
|
31,031 |
23,067 |
$12K |
| 77062 |
|
503 |
487 |
$12K |
| 73560 |
|
3,729 |
3,092 |
$12K |
| 20550 |
|
159 |
127 |
$12K |
| J1453 |
Injection, fosaprepitant, 1 mg |
609 |
401 |
$12K |
| 92250 |
|
3,137 |
2,883 |
$12K |
| 51702 |
|
895 |
752 |
$11K |
| 97760 |
|
813 |
721 |
$11K |
| 73110 |
|
4,061 |
3,217 |
$11K |
| 97763 |
|
683 |
548 |
$11K |
| 94799 |
|
10,453 |
5,891 |
$11K |
| 96402 |
|
533 |
460 |
$11K |
| 75561 |
|
88 |
79 |
$11K |
| 96158 |
|
349 |
261 |
$11K |
| 93922 |
|
570 |
537 |
$10K |
| 87517 |
|
456 |
405 |
$10K |
| 83521 |
|
692 |
578 |
$10K |
| 85046 |
|
2,322 |
1,804 |
$10K |
| 82103 |
|
726 |
631 |
$10K |
| 99396 |
|
225 |
218 |
$10K |
| 84155 |
|
3,981 |
3,315 |
$10K |
| 77295 |
|
55 |
40 |
$10K |
| 87184 |
|
2,203 |
1,630 |
$10K |
| 86225 |
|
1,107 |
974 |
$10K |
| 73590 |
|
3,535 |
2,776 |
$10K |
| 84165 |
|
1,889 |
1,593 |
$9K |
| 38222 |
|
65 |
52 |
$9K |
| 80177 |
|
562 |
509 |
$9K |
| 0202U |
|
578 |
524 |
$9K |
| 82024 |
|
147 |
135 |
$9K |
| 87902 |
|
52 |
43 |
$9K |
| 95930 |
|
56 |
55 |
$9K |
| 83525 |
|
678 |
632 |
$9K |
| 92587 |
|
360 |
342 |
$9K |
| 67311 |
|
12 |
12 |
$9K |
| 80375 |
|
519 |
465 |
$9K |
| 80178 |
|
339 |
266 |
$9K |
| 73700 |
|
254 |
203 |
$9K |
| 51798 |
|
4,121 |
3,700 |
$9K |
| 42830 |
|
20 |
19 |
$9K |
| 72040 |
|
2,245 |
2,022 |
$9K |
| 90656 |
|
1,066 |
1,042 |
$8K |
| 72100 |
|
2,894 |
2,637 |
$8K |
| 83992 |
|
520 |
466 |
$8K |
| 90723 |
|
2,265 |
2,203 |
$8K |
| G0379 |
Direct admission of patient for hospital observation care |
337 |
294 |
$8K |
| 96132 |
|
58 |
50 |
$8K |
| 11900 |
|
158 |
150 |
$8K |
| 94664 |
|
930 |
857 |
$8K |
| 82378 |
|
490 |
427 |
$8K |
| 96120 |
|
87 |
69 |
$8K |
| 36561 |
|
26 |
24 |
$8K |
| 86334 |
|
800 |
669 |
$8K |
| 88304 |
|
2,503 |
2,046 |
$8K |
| 43249 |
|
42 |
36 |
$8K |
| 85045 |
|
2,743 |
2,247 |
$8K |
| 88185 |
|
1,475 |
831 |
$8K |
| 73140 |
|
2,027 |
1,699 |
$8K |
| 86618 |
|
545 |
485 |
$8K |
| 84425 |
|
588 |
531 |
$8K |
| 31231 |
|
331 |
309 |
$7K |
| 80324 |
|
518 |
464 |
$7K |
| 86644 |
|
744 |
609 |
$7K |
| 82248 |
|
1,799 |
1,466 |
$7K |
| 92556 |
|
584 |
538 |
$7K |
| 73552 |
|
2,072 |
1,704 |
$7K |
| 88184 |
|
1,043 |
871 |
$7K |
| 17311 |
|
46 |
37 |
$7K |
| 82010 |
|
955 |
707 |
$7K |
| 86787 |
|
1,098 |
904 |
$7K |
| 82390 |
|
731 |
641 |
$7K |
| 73080 |
|
2,020 |
1,724 |
$7K |
| 76981 |
|
421 |
406 |
$7K |
| 73564 |
|
1,769 |
1,447 |
$7K |
| 96164 |
|
159 |
87 |
$7K |
| 77065 |
Tomosynthesis, mammo |
540 |
466 |
$7K |
| 88142 |
|
409 |
362 |
$7K |
| 77073 |
|
979 |
924 |
$6K |
| 92608 |
|
227 |
219 |
$6K |
| 85007 |
|
1,500 |
1,057 |
$6K |
| 95910 |
|
186 |
176 |
$6K |
| 11104 |
|
56 |
53 |
$6K |
| 83002 |
|
414 |
374 |
$6K |
| 86765 |
|
650 |
571 |
$6K |
| 86200 |
|
589 |
532 |
$6K |
| 75574 |
|
73 |
56 |
$6K |
| 73562 |
|
3,183 |
2,743 |
$6K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
35,950 |
31,412 |
$6K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
82 |
67 |
$5K |
| 31720 |
|
363 |
291 |
$5K |
| 88313 |
|
3,544 |
2,177 |
$5K |
| 94762 |
|
67 |
53 |
$5K |
| J0185 |
Injection, aprepitant, 1 mg |
177 |
116 |
$5K |
| 0004A |
|
834 |
710 |
$5K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
74 |
66 |
$5K |
| 88312 |
|
1,636 |
1,005 |
$5K |
| 87625 |
|
210 |
187 |
$5K |
| 73100 |
|
1,245 |
924 |
$5K |
| 90620 |
|
179 |
177 |
$5K |
| 86735 |
|
564 |
497 |
$5K |
| 86665 |
|
414 |
259 |
$5K |
| 96416 |
|
38 |
26 |
$5K |
| 77091 |
|
692 |
645 |
$5K |
| 81002 |
|
269 |
241 |
$5K |
| J1611 |
Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg |
172 |
152 |
$4K |
| 76817 |
|
319 |
292 |
$4K |
| 12002 |
|
74 |
68 |
$4K |
| 84255 |
|
212 |
210 |
$4K |
| 78264 |
|
36 |
36 |
$4K |
| 99152 |
|
5,006 |
4,517 |
$4K |
| 80076 |
|
113 |
103 |
$4K |
| 90707 |
|
817 |
787 |
$4K |
| 82610 |
|
297 |
277 |
$4K |
| 95812 |
|
32 |
30 |
$4K |
| 88112 |
|
1,431 |
1,258 |
$4K |
| Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg |
25 |
12 |
$4K |
| 87338 |
|
96 |
95 |
$4K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
264 |
245 |
$4K |
| 73070 |
|
1,384 |
988 |
$4K |
| 11100 |
|
70 |
68 |
$4K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
32,056 |
20,525 |
$4K |
| 84446 |
|
308 |
293 |
$3K |
| 74220 |
|
137 |
129 |
$3K |
| 77061 |
|
126 |
113 |
$3K |
| 91200 |
|
340 |
316 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
36,342 |
30,967 |
$3K |
| 51600 |
|
89 |
80 |
$3K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
2,793 |
2,508 |
$3K |
| 77280 |
|
62 |
40 |
$3K |
| 94761 |
|
6,303 |
5,562 |
$3K |
| 82104 |
|
300 |
262 |
$3K |
| 0124A |
|
262 |
252 |
$3K |
| 74240 |
|
32 |
27 |
$3K |
| 90696 |
|
409 |
394 |
$3K |
| 90732 |
|
707 |
637 |
$3K |
| 90832 |
|
54 |
39 |
$3K |
| 90685 |
|
102 |
98 |
$3K |
| 90714 |
|
463 |
422 |
$3K |
| 90847 |
|
50 |
27 |
$3K |
| 96153 |
|
576 |
241 |
$3K |
| 90846 |
|
38 |
25 |
$3K |
| 90381 |
|
20 |
19 |
$3K |
| 86015 |
|
371 |
342 |
$3K |
| 97750 |
|
259 |
226 |
$3K |
| 84590 |
|
313 |
300 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,679 |
3,167 |
$3K |
| 62323 |
|
13 |
12 |
$2K |
| 76815 |
|
633 |
562 |
$2K |
| 0054A |
|
237 |
233 |
$2K |
| 82951 |
|
38 |
38 |
$2K |
| 77072 |
|
233 |
226 |
$2K |
| 77081 |
|
343 |
323 |
$2K |
| 70487 |
|
28 |
26 |
$2K |
| 29065 |
|
31 |
26 |
$2K |
| 90833 |
|
15 |
12 |
$2K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
105 |
99 |
$2K |
| 82945 |
|
135 |
108 |
$2K |
| 92136 |
|
493 |
452 |
$2K |
| 83921 |
|
153 |
141 |
$2K |
| 89050 |
|
262 |
200 |
$2K |
| P9045 |
Infusion, albumin (human), 5%, 250 ml |
50 |
27 |
$2K |
| 95974 |
|
12 |
12 |
$2K |
| 92553 |
|
30 |
28 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
29,437 |
25,600 |
$2K |
| G0659 |
Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes |
40 |
40 |
$2K |
| 0071A |
|
327 |
242 |
$2K |
| 72198 |
|
12 |
12 |
$2K |
| 86308 |
|
350 |
324 |
$2K |
| G0249 |
Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests |
214 |
205 |
$2K |
| J1610 |
Injection, glucagon hydrochloride, per 1 mg |
69 |
66 |
$2K |
| 88172 |
|
577 |
272 |
$2K |
| 84402 |
|
102 |
89 |
$2K |
| 74019 |
|
889 |
809 |
$2K |
| 93246 |
|
136 |
123 |
$2K |
| 86376 |
|
205 |
190 |
$2K |
| 84207 |
|
113 |
109 |
$2K |
| 76885 |
|
25 |
25 |
$2K |
| 82379 |
|
108 |
104 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
7,579 |
6,606 |
$2K |
| 82397 |
|
81 |
81 |
$2K |
| 76856 |
|
73 |
65 |
$2K |
| 85576 |
|
141 |
56 |
$2K |
| 90700 |
|
546 |
525 |
$2K |
| 90691 |
|
264 |
245 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
29,583 |
23,748 |
$2K |
| 90710 |
|
518 |
483 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
46,806 |
37,939 |
$2K |
| 88360 |
|
497 |
248 |
$2K |
| 85246 |
|
96 |
85 |
$2K |
| 83718 |
|
471 |
423 |
$2K |
| 85245 |
|
94 |
84 |
$2K |
| 85520 |
|
135 |
119 |
$2K |
| 76700 |
|
12 |
12 |
$2K |
| 73060 |
|
699 |
563 |
$2K |
| 77085 |
|
189 |
170 |
$2K |
| 0072A |
|
236 |
210 |
$2K |
| 92551 |
|
55 |
55 |
$2K |
| 86304 |
|
93 |
77 |
$2K |
| 81015 |
|
111 |
106 |
$2K |
| 99212 |
|
39 |
39 |
$2K |
| 51728 |
|
39 |
37 |
$2K |
| 82627 |
|
58 |
54 |
$2K |
| 96409 |
|
1,058 |
670 |
$1K |
| C8928 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report |
30 |
28 |
$1K |
| 82340 |
|
189 |
159 |
$1K |
| 86381 |
|
141 |
134 |
$1K |
| 87634 |
|
14 |
13 |
$1K |
| 86431 |
|
409 |
384 |
$1K |
| 80305 |
|
49 |
43 |
$1K |
| 74420 |
|
30 |
27 |
$1K |
| 97802 |
|
193 |
182 |
$1K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
1,052 |
1,008 |
$1K |
| 99153 |
Mod sedat endo service >5yrs |
4,344 |
3,807 |
$1K |
| 62270 |
|
12 |
12 |
$1K |
| 80195 |
|
41 |
25 |
$1K |
| 0241U |
|
32 |
15 |
$1K |
| 93298 |
|
122 |
120 |
$1K |
| M0220 |
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring |
26 |
24 |
$1K |
| 90472 |
|
3,777 |
2,983 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
23,461 |
19,416 |
$1K |
| 96401 |
|
228 |
88 |
$1K |
| 90739 |
|
216 |
197 |
$1K |
| 70549 |
|
12 |
12 |
$1K |
| 51726 |
|
14 |
12 |
$1K |
| 78306 |
|
12 |
12 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
35,229 |
14,319 |
$1K |
| 87071 |
|
32 |
27 |
$1K |
| 97803 |
|
288 |
279 |
$1K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
59 |
55 |
$1K |
| 92591 |
|
15 |
13 |
$1K |
| C1776 |
Joint device (implantable) |
364 |
306 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
26,220 |
20,819 |
$1K |
| 84134 |
|
333 |
300 |
$993.27 |
| 99070 |
|
113 |
109 |
$970.73 |
| C1760 |
Closure device, vascular (implantable/insertable) |
1,353 |
1,184 |
$960.72 |
| 82657 |
|
15 |
12 |
$950.19 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
9,403 |
7,306 |
$936.25 |
| J1756 |
Injection, iron sucrose, 1 mg |
316 |
182 |
$935.13 |
| 92652 |
|
13 |
12 |
$926.49 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
15,509 |
13,608 |
$922.68 |
| C1769 |
Guide wire |
3,777 |
3,092 |
$921.94 |
| 87088 |
|
127 |
110 |
$917.65 |
| 84681 |
|
247 |
229 |
$906.65 |
| 76512 |
|
44 |
39 |
$904.72 |
| 82542 |
|
16 |
15 |
$895.79 |
| 83090 |
|
56 |
50 |
$866.97 |
| 85347 |
|
380 |
114 |
$839.82 |
| 90717 |
|
33 |
33 |
$825.76 |
| 90694 |
|
440 |
382 |
$811.07 |
| 84157 |
|
198 |
162 |
$802.60 |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
16 |
15 |
$799.14 |
| 97810 |
|
233 |
122 |
$779.56 |
| 80183 |
|
25 |
24 |
$772.98 |
| 90662 |
|
405 |
372 |
$768.04 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
1,902 |
1,675 |
$763.58 |
| 93299 |
|
12 |
12 |
$750.87 |
| 36416 |
|
1,220 |
1,062 |
$746.12 |
| 80346 |
|
519 |
465 |
$735.09 |
| 0121A |
|
71 |
61 |
$732.08 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
9,838 |
7,684 |
$728.33 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,597 |
3,052 |
$724.84 |
| 83498 |
|
29 |
27 |
$706.50 |
| 91300 |
|
169 |
140 |
$697.99 |
| J2060 |
Injection, lorazepam, 2 mg |
3,728 |
3,086 |
$678.54 |
| 73600 |
|
1,112 |
951 |
$674.09 |
| 84300 |
|
316 |
264 |
$667.86 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
731 |
644 |
$656.74 |
| 92520 |
|
13 |
13 |
$648.34 |
| 74455 |
|
14 |
12 |
$647.46 |
| 95912 |
|
12 |
12 |
$643.79 |
| 70250 |
|
48 |
45 |
$642.68 |
| 86036 |
|
92 |
84 |
$640.55 |
| 97164 |
|
13 |
12 |
$639.91 |
| 92025 |
|
327 |
310 |
$625.87 |
| 98960 |
|
411 |
388 |
$624.55 |
| 17000 |
|
28 |
24 |
$617.47 |
| 95713 |
|
12 |
12 |
$603.35 |
| 91321 |
|
236 |
230 |
$602.59 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,891 |
1,682 |
$598.82 |
| 82435 |
|
261 |
226 |
$597.73 |
| 85240 |
|
79 |
70 |
$590.70 |
| 88173 |
|
831 |
425 |
$589.26 |
| 86361 |
|
38 |
28 |
$583.23 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
7,088 |
5,469 |
$579.55 |
| 84432 |
|
29 |
26 |
$569.34 |
| 77090 |
|
122 |
112 |
$561.41 |
| 84270 |
|
28 |
28 |
$542.66 |
| 86800 |
|
49 |
47 |
$537.06 |
| 87449 |
|
93 |
52 |
$528.15 |
| 83876 |
|
40 |
38 |
$519.75 |
| 80364 |
|
790 |
714 |
$519.60 |
| 62368 |
|
31 |
27 |
$514.12 |
| A9581 |
Injection, gadoxetate disodium, 1 ml |
251 |
224 |
$497.49 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
8,591 |
6,602 |
$493.74 |
| 84244 |
|
25 |
25 |
$484.92 |
| 87116 |
|
80 |
55 |
$474.33 |
| 80326 |
|
266 |
244 |
$454.74 |
| A9573 |
Injection, gadopiclenol, 1 ml |
2,809 |
2,605 |
$444.48 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
3,787 |
3,332 |
$441.76 |
| J1815 |
Injection, insulin, per 5 units |
5,443 |
2,238 |
$441.74 |
| J3480 |
Injection, potassium chloride, per 2 meq |
2,933 |
2,099 |
$441.26 |
| 87385 |
|
79 |
53 |
$422.89 |
| 88237 |
|
14 |
12 |
$421.64 |
| 59025 |
|
22 |
12 |
$419.93 |
| 87427 |
|
29 |
25 |
$418.79 |
| 86709 |
|
47 |
43 |
$409.51 |
| J2997 |
Injection, alteplase recombinant, 1 mg |
27 |
25 |
$403.21 |
| 76825 |
|
15 |
13 |
$402.13 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
2,406 |
2,067 |
$400.53 |
| 84478 |
|
35 |
27 |
$397.95 |
| 83010 |
|
58 |
38 |
$394.05 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
4,073 |
3,424 |
$392.61 |
| 80359 |
|
527 |
472 |
$387.81 |
| J1644 |
Injection, heparin sodium, per 1000 units |
5,919 |
3,049 |
$385.66 |
| 93280 |
|
24 |
24 |
$385.57 |
| 80372 |
|
520 |
466 |
$381.20 |
| 80356 |
|
520 |
466 |
$381.20 |
| 70355 |
|
15 |
13 |
$379.00 |
| 80358 |
|
520 |
466 |
$378.57 |
| 80373 |
|
520 |
466 |
$378.57 |
| 80353 |
|
520 |
466 |
$377.25 |
| 80348 |
|
520 |
466 |
$377.25 |
| 80354 |
|
520 |
466 |
$377.25 |
| 80360 |
|
520 |
466 |
$377.25 |
| 80361 |
|
520 |
466 |
$377.25 |
| 80365 |
|
520 |
466 |
$377.25 |
| 83883 |
|
71 |
38 |
$368.90 |
| 86301 |
|
38 |
37 |
$362.37 |
| 80176 |
|
70 |
59 |
$357.55 |
| 82239 |
|
27 |
27 |
$353.80 |
| 85613 |
|
42 |
40 |
$352.25 |
| 90672 |
|
20 |
19 |
$338.87 |
| 97035 |
|
51 |
27 |
$328.29 |
| 93880 |
|
14 |
13 |
$321.66 |
| 92060 |
|
122 |
115 |
$312.46 |
| 95991 |
|
16 |
12 |
$291.12 |
| 96411 |
|
613 |
392 |
$285.92 |
| 82652 |
|
12 |
12 |
$283.52 |
| 72070 |
|
273 |
237 |
$277.76 |
| 86039 |
|
35 |
31 |
$274.22 |
| 88331 |
|
152 |
127 |
$273.42 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
4,393 |
1,879 |
$271.85 |
| 97032 |
|
16 |
13 |
$270.25 |
| G0380 |
Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
69 |
50 |
$261.59 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
3,601 |
3,220 |
$261.21 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
22,627 |
12,118 |
$258.00 |
| 80347 |
|
267 |
245 |
$256.52 |
| 82374 |
|
91 |
79 |
$256.24 |
| 85732 |
|
42 |
40 |
$251.73 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
11,847 |
7,932 |
$248.80 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
988 |
789 |
$245.47 |
| J2785 |
Injection, regadenoson, 0.1 mg |
220 |
197 |
$242.39 |
| 86705 |
|
34 |
26 |
$238.20 |
| 85250 |
|
16 |
13 |
$236.04 |
| 97811 |
|
190 |
90 |
$232.18 |
| 86147 |
|
18 |
13 |
$231.57 |
| C1729 |
Catheter, drainage |
462 |
406 |
$226.06 |
| 90653 |
|
103 |
99 |
$220.98 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
3,519 |
2,933 |
$220.12 |
| 76376 |
|
683 |
628 |
$216.65 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
8,732 |
4,204 |
$213.68 |
| J1630 |
Injection, haloperidol, up to 5 mg |
3,311 |
2,837 |
$204.46 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
2,412 |
2,064 |
$196.86 |
| 86357 |
|
13 |
12 |
$195.38 |
| 0003A |
|
20 |
20 |
$194.96 |
| 20561 |
|
127 |
87 |
$194.70 |
| 76827 |
|
15 |
13 |
$191.48 |
| 0081A |
|
24 |
23 |
$190.80 |
| J9370 |
Vincristine sulfate, 1 mg |
505 |
301 |
$187.53 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,045 |
2,305 |
$186.30 |
| 76391 |
|
15 |
13 |
$185.70 |
| 51797 |
|
42 |
40 |
$178.82 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
3,182 |
2,655 |
$177.63 |
| 88311 |
|
552 |
440 |
$175.55 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
11,325 |
6,948 |
$175.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
3,935 |
2,819 |
$170.29 |
| 97542 |
|
13 |
12 |
$168.46 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,139 |
2,719 |
$160.74 |
| 82139 |
|
15 |
13 |
$160.32 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
2,573 |
1,678 |
$156.77 |
| 73000 |
|
395 |
331 |
$146.02 |
| J0697 |
Injection, sterile cefuroxime sodium, per 750 mg |
5,440 |
2,961 |
$142.10 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
3,297 |
2,797 |
$139.89 |
| 80355 |
|
267 |
245 |
$139.81 |
| 99188 |
|
881 |
835 |
$137.26 |
| 82232 |
|
28 |
12 |
$132.21 |
| 87350 |
|
14 |
13 |
$123.30 |
| 87176 |
|
37 |
24 |
$122.54 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,499 |
1,982 |
$118.67 |
| J3411 |
Injection, thiamine hcl, 100 mg |
1,762 |
1,375 |
$112.61 |
| 86707 |
|
13 |
12 |
$109.08 |
| 87106 |
|
12 |
12 |
$106.94 |
| 36591 |
|
64 |
40 |
$106.11 |
| 82952 |
|
26 |
26 |
$101.25 |
| 85384 |
|
46 |
13 |
$101.19 |
| 92201 |
|
277 |
267 |
$98.10 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
540 |
274 |
$93.55 |
| 0082A |
|
13 |
13 |
$90.24 |
| 87045 |
|
29 |
25 |
$87.27 |
| 92511 |
|
37 |
37 |
$82.60 |
| 91312 |
|
547 |
510 |
$81.90 |
| 95970 |
|
41 |
40 |
$81.25 |
| 99459 |
|
32 |
26 |
$77.36 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,119 |
926 |
$76.74 |
| 95012 |
|
57 |
52 |
$73.87 |
| 96165 |
|
168 |
86 |
$71.83 |
| 82085 |
|
12 |
12 |
$71.09 |
| 83930 |
|
15 |
13 |
$70.14 |
| 83935 |
|
13 |
12 |
$65.19 |
| 87305 |
|
16 |
12 |
$61.90 |
| 91318 |
|
18 |
18 |
$55.56 |
| 85660 |
|
14 |
13 |
$51.38 |
| 86880 |
|
24 |
12 |
$50.13 |
| 86886 |
|
18 |
12 |
$50.00 |
| 77293 |
|
13 |
12 |
$47.00 |
| 51701 |
|
13 |
12 |
$45.52 |
| J0613 |
Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg |
45 |
25 |
$42.55 |
| 84540 |
|
34 |
24 |
$41.36 |
| C9399 |
Unclassified drugs or biologicals |
584 |
522 |
$40.32 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
2,037 |
1,835 |
$39.11 |
| 0051A |
|
12 |
12 |
$38.16 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
3,532 |
2,785 |
$35.96 |
| A4648 |
Tissue marker, implantable, any type, each |
994 |
918 |
$34.25 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
5,727 |
1,974 |
$32.89 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,378 |
1,117 |
$32.76 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
379 |
318 |
$32.15 |
| 97150 |
|
20 |
12 |
$31.90 |
| 87046 |
|
31 |
25 |
$28.39 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,836 |
2,176 |
$27.56 |
| 96159 |
|
121 |
84 |
$25.74 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
1,288 |
653 |
$25.43 |
| 77001 |
|
105 |
97 |
$23.04 |
| 95250 |
|
14 |
14 |
$22.92 |
| 90474 |
|
516 |
471 |
$22.40 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
306 |
278 |
$19.84 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
5,427 |
2,384 |
$19.21 |
| J1790 |
Injection, droperidol, up to 5 mg |
840 |
728 |
$18.76 |
| 36592 |
|
16 |
15 |
$18.47 |
| 96381 |
|
31 |
30 |
$18.15 |
| 73660 |
|
15 |
14 |
$18.07 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
851 |
773 |
$16.74 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
1,627 |
1,227 |
$10.51 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
491 |
380 |
$8.98 |
| G0009 |
Administration of pneumococcal vaccine |
124 |
116 |
$8.74 |
| A4215 |
Needle, sterile, any size, each |
572 |
477 |
$8.08 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,465 |
1,105 |
$6.32 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
367 |
277 |
$5.95 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
87 |
54 |
$4.63 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
190 |
159 |
$4.23 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
224 |
188 |
$4.10 |
| J1940 |
Injection, furosemide, up to 20 mg |
482 |
304 |
$3.62 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
427 |
223 |
$3.06 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
353 |
316 |
$2.60 |
| J1836 |
Injection, metronidazole, 10 mg |
223 |
148 |
$2.16 |
| A6211 |
Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing |
31 |
25 |
$1.78 |
| J1953 |
Injection, levetiracetam, 10 mg |
205 |
160 |
$1.58 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
779 |
558 |
$1.20 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
36 |
26 |
$1.15 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
85 |
80 |
$0.77 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
627 |
368 |
$0.36 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
235 |
201 |
$0.28 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
343 |
315 |
$0.00 |
| J2560 |
Injection, phenobarbital sodium, up to 120 mg |
164 |
128 |
$0.00 |
| 91317 |
|
18 |
18 |
$0.00 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
13 |
13 |
$0.00 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
61 |
56 |
$0.00 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
69 |
50 |
$0.00 |
| 72020 |
|
62 |
52 |
$0.00 |
| 42975 |
|
74 |
71 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
210 |
188 |
$0.00 |
| J9045 |
Injection, carboplatin, 50 mg |
46 |
25 |
$0.00 |
| G8998 |
Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting |
42 |
39 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
43 |
41 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
65 |
59 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
34 |
28 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
44 |
42 |
$0.00 |
| 72190 |
|
13 |
12 |
$0.00 |
| C2624 |
Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components |
35 |
27 |
$0.00 |
| 72080 |
|
13 |
12 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
81 |
63 |
$0.00 |
| J9250 |
Methotrexate sodium, 5 mg |
53 |
24 |
$0.00 |
| J1805 |
Injection, esmolol hydrochloride, 10 mg |
32 |
28 |
$0.00 |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
16 |
16 |
$0.00 |
| J2305 |
Injection, nitroglycerin, 5 mg |
67 |
61 |
$0.00 |
| 91315 |
|
55 |
53 |
$0.00 |
| 94668 |
|
27 |
13 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
17 |
15 |
$0.00 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
12 |
12 |
$0.00 |
| A9300 |
Exercise equipment |
25 |
24 |
$0.00 |
| 91307 |
|
13 |
12 |
$0.00 |
| 91305 |
|
12 |
12 |
$0.00 |
| 90461 |
|
235 |
226 |
$0.00 |
| 91308 |
|
103 |
101 |
$0.00 |
| 92202 |
|
61 |
54 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
26 |
24 |
$0.00 |
| 99177 |
|
728 |
703 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
643 |
566 |
$0.00 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
260 |
239 |
$0.00 |
| 90460 |
|
392 |
373 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
230 |
201 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
248 |
215 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
706 |
615 |
$0.00 |
| 95983 |
|
15 |
12 |
$0.00 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
42 |
39 |
$0.00 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
60 |
46 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
33 |
25 |
$0.00 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
81 |
69 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
99 |
89 |
$0.00 |
| 29105 |
|
12 |
12 |
$0.00 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
42 |
39 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
59 |
39 |
$0.00 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
13 |
13 |
$0.00 |
| 69209 |
|
13 |
12 |
$0.00 |
| J9999 |
Not otherwise classified, antineoplastic drugs |
64 |
26 |
$0.00 |
| 77387 |
|
92 |
12 |
$0.00 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
45 |
32 |
$0.00 |
| A9999 |
Miscellaneous dme supply or accessory, not otherwise specified |
32 |
27 |
$0.00 |
| J3489 |
Injection, zoledronic acid, 1 mg |
12 |
12 |
$0.00 |
| 77089 |
|
12 |
12 |
$0.00 |
| Q9958 |
High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
16 |
14 |
$0.00 |
| E1390 |
Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate |
16 |
13 |
$0.00 |